College of Medicine


Appointed to University of Saskatchewan 1977.

Contributions to Respiratory Medicine: Implemented high volume, low pressure endotracheal tubes for Respiratory Intensive Care patients; added the effect of sleep on breathing and obstructive sleep apnea to the curriculum for second year medical students; implemented ambulatory supplementary oxygen therapy for home management of COPD; pioneered nighttime ventilation for patients with respiratory failure secondary to kyphoscoliosis; identified and treated Saskatchewan’s first patient with obstructive sleep apnea; developed in collaboration with neurology the initial diagnostic capacity for identification of sleep apnea; pioneered directly observed therapy for Saskatchewan patients with TB and TB infection, the first jurisdiction in North America to provide this service; pioneered mobile TB clinics for Saskatchewan in collaboration with Health Canada, Saskatchewan Region.


  • Fellowship Immunology of Tuberculosis and Related Diseases British Medical Research Council
  • FRCPC Respiratory Diseases
  • FRCPC Internal Medicine
  • General Medicine training University of Toronto
  • Respiratory Specialty training University of Toronto
  • Doctor of Medicine University of Manitoba


Faculty Appointments

  • Assistant/Associate/Professor Respiratory Medicine 1977-88.
  • Chair Respiratory Systems teaching for 2nd year students
  • JURSI Program Coordinator Department of Medicine
  • Medical Director Intensive Care Unit
  • Chair Respiratory Training Program
  • Head Department of Medicine
  • Acting Head Division Respiratory, Critical Care & Sleep Medicine

Professional Association/Administrative/Community Contributions

  • President Saskatchewan Thoracic Society
  • Board of Directors Canadian Thoracic Society
  • Chair Technical Working Group for Home Respiratory Therapy, SAIL, Saskatchewan Health
  • Medical Director Saskatchewan Tuberculosis Program, Saskatchewan Health
  • World Health Organization Sub-committee on the Diagnosis of Tuberculosis
  • Chair Canadian Tuberculosis Committee, Health Canada
  • Associate Editor Canadian TB Standards, 5th and 6th Editions.
  • Board of Directors Lung Association of Saskatchewan
  • Chair Governance Committee Lung Association of Saskatchewan

Clinical Interests

  • Tuberculosis

Selected Publications

  • V.H. Hoeppner, D.M. Cooper, N. Zamel, A.C. Bryan and L. Levison, 1974. Relationship Between the Elastic Recoil in Closing Volume in Smokers and Non-Smokers.  American Review of Respiratory Disease 109:81-86
  • V.H. Hoeppner. 1982. Orthocyanosis:  A Sign of Pulmonary Arteriovenous Malformation.   Thorax 37:952-953.
  • V.H. Hoeppner. D.W. Cockcroft, J.A. Dosman, D.J. Cotton. 1984. Night-time Ventilation Improves Respiratory Failure in Kyphoscoliosis. American Review of Respiratory Disease 129:240-243.
  • V.H. Hoeppner, P.S. Jackett, J.S. Beck, T. Kardjito, J.M. Grange, J. Ivanyi. 1987 Appraisal of the Monoclonal Antibody-based Competition Test for the Serology of Tuberculosis in Indonesia.  Serodiagnosis and Immunotherapy. 1:69-77.
  • W. Wobeser, T. To, V.H. Hoeppner, 1989.  The Outcome of Chemoprophylaxis on Tuberculosis Prevention in the Canadian Plains Indian.  Clin Invest Med 12:149-153.
  • C. Mcparland, D.J.Cotton, K.S. Gowda, V.H. Hoeppner, W.T. Martin, P.F. Weckworth, 1992.  Miliary Mycobacterium bovis induced by intravesical Bacille Calmette-Guerin immunotherapy.  Am Rev Resp Dis. 146:1330-33.   16.
  • G. Soparkar, I. Mayers, L. Edouard, V.H. Hoeppner, 1993.     Toxic effects from nitrogen dioxide in ice-skating arenas.   Can Med Assoc J.148:1181-82.
  • Marciniuk DD, McNab BD, Hoeppner VH.  Detection of pulmonary tuberculosis in patients with a normal chest radiograph. Chest 1999; 115:445-52.
  • McNab BD, Marciniuk DD, Alvi RA,Tan L, Hoeppner VH, 2000.  Twice Weekly Isoniazid and Rifampin Treatment of Latent Tuberculosis Infection in Canadian Plains Aborigines. Am J Resp Crit Care Med. 162: 989-993.
  • V.H. Hoeppner, D.D. Marciniuk, 2000.  Tuberculosis in Aboriginal Canadians. Can Respir J. 7:141-146.
  • Hoeppner VH, Marciniuk DD, Hershfield ES.  2000. Treatment of Tuberculosis and Latent Tuberculosis Infection, in Canadian Tuberculosis Standards, 5th Ed., ed R. Long, CLA/LCDC, Ottawa
  • Reid JM, Marciniuk DD, Peloquin CA, Hoeppner VH, 2002.  Pharmacokinetics of antituberculosis medication delivered via percutaneous gastrojejunostomy tube.  Chest 121: 281-288.
  • Ward HA, Marciniuk DD, Pahwa P, Hoeppner VH.  Extent of pulmonary tuberculosis in patients diagnosed by active versus passive case finding.  Int J Tuberc Lung Dis 2004; 8: 593-597.
  • Reid JK, Ward H, Marciniuk D, Hudson S, Smith P, Hoeppner VH. The Effect of Neonatal BCG Vaccination on PPD testing on Canadian Aboriginal Children. Chest 2007; 131: 1806-10.
  • Hoeppner VH, Ward, HA, Elwood K. 2007. Treatment of Tuberculosis Disease and Infection, in Canadian Tuberculosis Standards, 6th Ed, ed R. Long and E. Ellis, CLA/PHAC Ottawa
  • Pepperell C, Hoeppner VH, Lipatov M, Wobeser W, Schoolnik GK, Feldman MW. Bacterial genetic signatures of human social phenomena among M.tuberculosis from an Aboriginal Canadian population. Mol Biol Evol; 2010; 27: 427-40.
  • Tian Y, Osgood N, Al-Azem, A, Hoeppner V. Evaluating the effectiveness of contact tracing on tuberculosis outcomes in Saskatchewan using agent-based modeling. Health Education and Behaviour 2013; 40 (IS): 98S-110S.